Literature DB >> 33441854

Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions.

Noe Garin1,2,3, Nuria Sole4, Beatriz Lucas4, Laia Matas5, Desiree Moras5, Ana Rodrigo-Troyano6, Laura Gras-Martin4, Nuria Fonts4.   

Abstract

Drug-related problems (DRP) cause preventable negative health outcomes, especially during hospital admissions. The aim of our study was to examine the prevalence and characteristics of DRP in regular clinical pharmacy, as well as to determine those factors associated with a higher risk of DRP in the hospital setting. We analyzed data from a standardized registry database of regular pharmacy practice (2015- 2016). DRP were classified according to the Pharmaceutical Care Network Europe v6.2 classification. Cross-sectional data were obtained from 1602 adults admitted to medical wards. Crude and adjusted binary logistic regressions were performed to identify associations between potential risk factors and DRP. Overall DRP prevalence was high across medical specialties (45,1%), in a population characterized by advanced age, polypharmacy and multimorbidity. Problems leading to DRP were mainly classified into two domains (effectiveness and adverse reactions), being drug and dose selection the most frequent causes. Interventions were accepted and DRP were totally or partially solved in 74.1% and 4.81% of cases, respectively. In the adjusted model polypharmacy, allergies, BMI > 25 kg/m2 and clearance < 30 mL/min were associated with a higher risk of DRP. The participation of clinical pharmacists into multidisciplinary teams promotes the detection and solution of DRP. Polypharmacy, obesity, renal impairment and allergy are associated with a higher risk of DRP during admission.

Entities:  

Year:  2021        PMID: 33441854      PMCID: PMC7807048          DOI: 10.1038/s41598-020-80560-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

Review 1.  Which drugs cause preventable admissions to hospital? A systematic review.

Authors:  R L Howard; A J Avery; S Slavenburg; S Royal; G Pipe; P Lucassen; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06-26       Impact factor: 4.335

2.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

Authors:  L L Leape; T A Brennan; N Laird; A G Lawthers; A R Localio; B A Barnes; L Hebert; J P Newhouse; P C Weiler; H Hiatt
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

3.  Drug-related problems in geriatric rehabilitation patients after discharge - A prevalence analysis and clinical case scenario-based pilot study.

Authors:  Johanna Freyer; Lucie Hueter; Lysann Kasprick; Thomas Frese; Ralf Sultzer; Susanne Schiek; Thilo Bertsche
Journal:  Res Social Adm Pharm       Date:  2017-07-25

4.  Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patients.

Authors:  Mitchell S Buckley; Lisa M Harinstein; Kimberly B Clark; Pamela L Smithburger; Doug J Eckhardt; Earnest Alexander; Sandeep Devabhakthuni; Craig A Westley; Butch David; Sandra L Kane-Gill
Journal:  Ann Pharmacother       Date:  2013-10-15       Impact factor: 3.154

5.  [Prevalence of polypharmacy among the population older than 65 years in Spain: Analysis of the 2006 and 2011/12 National Health Surveys].

Authors:  Mar Martin-Pérez; Ana López de Andrés; Valentín Hernández-Barrera; Rodrigo Jiménez-García; Isabel Jiménez-Trujillo; Domingo Palacios-Ceña; Pilar Carrasco-Garrido
Journal:  Rev Esp Geriatr Gerontol       Date:  2016-10-17

6.  Pharmacist- versus physician-obtained medication histories.

Authors:  Todd A Reeder; Alan Mutnick
Journal:  Am J Health Syst Pharm       Date:  2008-05-01       Impact factor: 2.637

7.  Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension.

Authors:  Rana Abu Farha; Iman Basheti; Hassan Abu Al Ruz; Akram Alsaleh; Salah AbuRuz
Journal:  Eur J Hosp Pharm       Date:  2015-10-16

8.  Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study.

Authors:  Gosaye Mekonen Tefera; Ameha Zewudie Zeleke; Yitagesu Mamo Jima; Tsegaye Melaku Kebede
Journal:  Drug Healthc Patient Saf       Date:  2020-05-04

9.  The Risks and Outcomes Resulting From Medication Errors Reported in the Finnish Tertiary Care Units:: A Cross-Sectional Retrospective Register Study.

Authors:  Outi Laatikainen; Sami Sneck; Miia Turpeinen
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

10.  The epidemiology of polypharmacy in older adults: register-based prospective cohort study.

Authors:  Lucas Morin; Kristina Johnell; Marie-Laure Laroche; Johan Fastbom; Jonas W Wastesson
Journal:  Clin Epidemiol       Date:  2018-03-12       Impact factor: 4.790

View more
  12 in total

1.  Pharmacists and community health workers improve medication-related process outcomes among Cambodian Americans with depression and risk for diabetes.

Authors:  Christina M Polomoff; Angela Bermudez-Millan; Thomas Buckley; Orfeu M Buxton; Richard Feinn; Sengly Kong; Theanvy Kuoch; Mackenzie Lim; Mary Scully; Julie Wagner
Journal:  J Am Pharm Assoc (2003)       Date:  2021-10-30

2.  Community pharmacists' routine provision of drug-related problem-reduction services.

Authors:  Ghaith M Al-Taani; Nehad M Ayoub
Journal:  PLoS One       Date:  2022-05-04       Impact factor: 3.240

3.  Risk factors for drug therapy problems among Cambodian Americans with complex needs: a cross-sectional, observational study.

Authors:  Julie A Wagner; Angela Bermudez-Millan; S Megan Berthold; Thomas Buckley; Orfeu M Buxton; Richard Feinn; Theanvy Kuoch; Sengly Kong; Mackenzie Lim; Christina Polomoff; Mary Scully
Journal:  Health Psychol Behav Med       Date:  2022-01-24

4.  Medication discrepancies among hospitalized patients with hypertension: assessment of prevalence and risk factors.

Authors:  Rana Abu Farha; Alaa Yousef; Lobna Gharaibeh; Waed Alkhalaileh; Tareq Mukattash; Eman Alefishat
Journal:  BMC Health Serv Res       Date:  2021-12-14       Impact factor: 2.655

5.  The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases.

Authors:  Huda Ismail; Vincent D Marshall; Minal Patel; Madiha Tariq; Rima A Mohammad
Journal:  J Am Pharm Assoc (2003)       Date:  2021-11-15

6.  Clinical pharmacists' interventions across German hospitals: results from a repetitive cross-sectional study.

Authors:  Claudia Langebrake; Carina Hohmann; Susanne Lezius; Michael Lueb; Gesine Picksak; Wencke Walter; Sandra Kaden; Heike Hilgarth; Angela Ihbe-Heffinger; Katja Leichenberg
Journal:  Int J Clin Pharm       Date:  2021-08-17

7.  Medication Errors and Type 2 Diabetes Management: A Qualitative Exploration of Physicians' Perceptions, Experiences and Expectations From Quetta City, Pakistan.

Authors:  Muhammad Kashif Habib; Muhammad Naeem Khan; Abdul Sadiq; Qaiser Iqbal; Abdul Raziq; Nafees Ahmad; Zaffar Iqbal; Sajjad Haider; Muhammad Anwar; Fazal Ur Rehman Khilji; Fahad Saleem; Amer Hayat Khan
Journal:  Front Med (Lausanne)       Date:  2022-03-28

8.  Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study.

Authors:  Amaury Durand; André Gillibert; Sophie Membre; Lisa Mondet; Aurélie Lenglet; Aurélien Mary
Journal:  Front Pharmacol       Date:  2022-03-23       Impact factor: 5.810

9.  Clinical Pharmacist Intervention on Drug-Related Problems among Elderly Patients Admitted to Medical Wards of Northwest Ethiopia Comprehensive Specialized Hospitals: A Multicenter Prospective, Observational Study.

Authors:  Samuel Berihun Dagnew; Gashaw Binega Mekonnen; Ejigu Gebeye Zeleke; Samuel Agegnew Wondm; Tesfaye Yimer Tadesse
Journal:  Biomed Res Int       Date:  2022-07-18       Impact factor: 3.246

10.  Impact of Clinical Pharmacist-Led Interventions on Drug-Related Problems Among Pediatric Cardiology Patients: First Palestinian Experience.

Authors:  Mohammed Kamel Elhabil; Mirghani Abdelrahman Yousif; Kannan O Ahmed; Mohamed Ibrahim Abunada; Khaled Ismail Almghari; Ahmed Salah Eldalo
Journal:  Integr Pharm Res Pract       Date:  2022-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.